Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-04-25 ¸ñ 23:13
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 407°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Interview]
Áö³ 10³â ¡®½ºÅ¸Æ¾°ú ´ç´¢º´ À§Ç衯 ´ã·Ð
ÇâÈÄ 10³â ½ºÅ¸Æ¾/ºñ½ºÅ¸Æ¾°è·Î
Q. ÀÌ»óÁöÁúÇ÷Áõ Ä¡·á¿¡ ÀÖ¾î ½ºÅ¸Æ¾ÀÇ ÇýÅÃÀº ¾î´À Á¤µµÀΰ¡?½ºÅ¸Æ¾Àº 1970³â´ë ·Î¹Ù½ºÅ¸Æ¾À» ÇʵηΠù ¼±À» º¸ÀÎ ÈÄ, 1990³â´ë ...
ÀÌ»óµ· ±âÀÚ
|
2023-03-10 16:19
¶óÀÎ
[Interview]
±¹³» ÃÖÃÊ SGLT-2¾ïÁ¦Á¦ À̳ªº¸±Û¸®Ç÷ÎÁø
Q. ÇöÀç±îÁöÀÇ R&D ¼º°ú¿Í ÇÔ²² ´ë¿õÁ¦¾àÀÇ ½Å¾à ÆÄÀÌÇÁ¶óÀο¡ ´ëÇØ °³°ýÀûÀ¸·Î ¼³¸íÇØ´Þ¶ó. ´ë¿õÁ¦¾àÀÇ ÃÖ±Ù R&D ¼º°ú´Â »ó´çÈ÷ °ý¸ñ...
THE MOST
|
2023-03-10 15:53
¶óÀÎ
[Conference Report]
ÇãÇ÷¼º ³úÁ¹Áß¿¡ ´ëÇÑ NOAC È¿°ú È®ÀÎ
¾ÆÇÈ»ç¹Ý Ä¡·á AF ȯÀÚ, ÇãÇ÷¼º ³úÁ¹Áß »ç¸Á À§Çè ³·¾Æ¼º³²½ÃÀÇ·á¿ø°ú ±¹¹Î°Ç°º¸Çè Àϻ꺴¿ø ¿¬±¸ÆÀÀº ÇãÇ÷¼º ³úÁ¹ÁßÀÌ ¹ß»ýÇÑ ½É¹æ¼¼µ¿ ȯ...
ÀÓ¼¼Çü ±âÀÚ
|
2023-03-10 13:45
¶óÀÎ
[Conference Report]
1ÀÏ 2ȸ DPP-4¾ïÁ¦Á¦ ½ÄÈÄÇ÷´ç ¡æ Ç÷´çº¯µ¿¼º °³¼±¿¡ ÃÖÀûÈ
¸íÁöº´¿ø ³»ºÐºñ³»°úÀÇ ÀÌÀçÇõ ±³¼ö´Â ¡®´ç´¢º´ Áø·áÁöħ ¹× ´ç´¢º´ Ä¡·á ÃÖ½ÅÁö°ß¡¯¿¡ ´ëÇØ °¿¬Çß´Ù. ÀÌ ±³¼ö´Â °¿¬¿¡¼ ÇöÀç ±¹³»¿Ü °¡ÀÌ...
ÀÌ»óµ· ±âÀÚ
|
2023-02-06 17:40
¶óÀÎ
[Late Breaking Studies]
´ç´¢º´ ȯÀÚ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·á¿¡ ¡®the lower¡¤earlier¡¤longer, the better¡¯
ÀúÆò°¡µÈ ½ÉÇ÷°üÁúȯ À§ÇèµµBanach ±³¼öÆÀÀº ¸®ºä³í¹®¿¡¼ ´ç´¢º´ ȯÀÚÀÇ ½ÉÇ÷°üÁúȯ À§Çèµµ°¡ ÀúÆò°¡(underestimated)µÅ ÀÖ°í, ÀÌ·Î ÀÎÇØ ´ç´¢º´ ȯÀÚµéÀÌ ½ÉÇ÷°üÁúȯ ¿¹¹æ°ú °ü·ÃÇØ ÀúÄ¡·á(undertreat...
ÀÌ»óµ· ±âÀÚ
|
2023-02-06 17:03
¶óÀÎ
[Sub Story]
°íÇ÷¾Ð¡¤ÀÌ»óÁöÁúÇ÷Áõ¡¤´ç´¢º´
°íÇ÷¾Ð°íÇ÷¾ÐÀº ³úÁ¹Áß ÀÌȯ ¹× »ç¸ÁÀÇ ÃÖ´ë À§ÇèÀÎÀÚ·Î ¾Ë·ÁÁ® ÀÖ´Ù. µû¶ó¼ AHA¡¤ASAÀÇ ³úÁ¹Áß 2Â÷¿¹¹æ °¡À̵å¶óÀο¡¼µµ ³úÁ¹Áß Àç¹ßÀ» ¹æÁöÇϱâ À§ÇØ Àû±ØÀûÀÎ Ç÷¾ÐÁ¶ÀýÀ» ÁÖ¹®ÇÏ°í ÀÖ´Ù. °íÇ÷¾ÐÀ» µ¿¹ÝÇÏ°í ÀÖ´Â ³úÁ¹...
ÀÌ»óµ· ±âÀÚ
|
2022-12-06 12:26
¶óÀÎ
[Sub Story]
½ºÅ¸Æ¾ ´Üµ¶¡¤ºñ½ºÅ¸Æ¾°è º´¿ë ³úÁ¹Áß ¿¹¹æÇýÅà ½Ã»ç
½ºÅ¸Æ¾½ºÅ¸Æ¾ Ä¡·áÀÇ ³úÁ¹Áß ¿¹¹æÈ¿°ú¸¦ ÀÔÁõÇÑ ´ëÇ¥Àû »ç·Ê·Î´Â SPARCL ¿¬±¸°¡ ÀÖ´Ù. ÇÁ¶û½º ºñ»þ´ëÇк´¿øÀÇ Pierre Amarenc...
ÀÌ»óµ· ±âÀÚ
|
2022-12-06 11:34
¶óÀÎ
[Conference Report]
ÇǸ¶»ç¸£Åº/½ºÅ¸Æ¾ SPC À¯È¿¼º¿¡ ³»¾à¼º¡¤¼øÀÀµµ±îÁö¡è
°íÇ÷¾Ð À¯º´·ü¡¤Á¶Àý·ü±è ±³¼ö´Â ¿ì¸®³ª¶ó ¼ºÀÎÀα¸ÀÇ °íÇ÷¾Ð À¯º´·üÀÌ 30% ´ë·Î ³ôÀº ¼öÁØÀ» À¯ÁöÇÏ°í ÀÖ´Â °¡¿îµ¥, Ç÷¾ÐÀ» ¸ñǥġ ¹Ì¸¸À¸...
ÀÌ»óµ· ±âÀÚ
|
2022-12-05 14:39
¶óÀÎ
[Late Breaking Studies]
Æä³ëÇǺ극ÀÌÆ® ½ÉÇ÷°ü ÇýÅà ±Ù°Å Ãß°¡
¸®¾ó¿ùµå ¿¬±¸ÀÇ ¹è°æÀ̹ø ¿¬±¸¿¡¼´Â Æä³ëÇǺ극ÀÌÆ®ÀÇ Áß¼ºÁö¹æ °¨¼ÒÈ¿°ú¿¡ ÃÊÁ¡À» ¸ÂÃè´Ù. ÀÌÀü¿¡ ÁøÇàµÈ Æä³ëÇǺ극ÀÌÆ®ÀÇ ´ëÇ¥ÀûÀÎ ¹«ÀÛÀ§ ´ëÁ¶±º ÀÓ»ó½ÃÇèÀÎ FIELD, ACCORD-Lipid ¿¬±¸¿¡¼´Â Æä³ëÇǺ극ÀÌÆ®°¡ ...
ÀÓ¼¼Çü ±âÀÚ
|
2022-12-05 14:24
¶óÀÎ
[Cover Story]
ÀÌ»óÁöÁúÇ÷Áõ Ä¡·á Æз¯´ÙÀÓÀº Çõ½Å Áß
¸ñǥġ ÇÏÇâÁ¶Á¤ ±¹¸éLDLÄÝ·¹½ºÅ×·Ñ Á¶Àý ¸ñǥġ¸¦ ÃÖ´ëÇÑ ÇÏÇâÁ¶Á¤ÇÏ´Â ÂÊÀ¸·Î ÀÌ»óÁöÁúÇ÷Áõ Ä¡·á Æз¯´ÙÀÓÀÌ »õ·Ó°Ô Çü¼ºµÇ°í ÀÖ´Ù. LDL...
ÀÌ»óµ· ±âÀÚ
|
2022-11-16 12:14
¶óÀÎ
[Sub Story]
Çѱ¹Àο¡¼ ½ºÅ¸Æ¾ÀÇ LDL-C °ÇÏÈ¿°ú
Çѱ¹Àο¡¼ ½ºÅ¸Æ¾ ¹ÝÀÀ·üÀ̹ø Áöħ¿¡¼ °ü½ÉÀ» ²ø¾ú´ø ´ë¸ñÀº ¡®Çѱ¹Àο¡¼ ½ºÅ¸Æ¾ÀÇ LDLÄÝ·¹½ºÅ×·Ñ °ÇÏÈ¿°ú¡¯¿¡ ´ëÇÑ ³»¿ëÀ̾ú´Ù. ÀüÅëÀûÀ¸...
ÀÌ»óµ· ±âÀÚ
|
2022-11-16 12:10
¶óÀÎ
[Sub Story]
´ëÇѹα¹Àº ¿Ö 55mg/dL ¹Ì¸¸ ¿Ü¸éÇÒ ¼ö ¾ø¾ú³ª?
2018 Áöħ → LDL-C £¼ 70mg/dL´ëÇѹα¹ÀÇ ÀÌ»óÁöÁúÇ÷Áõ °¡À̵å¶óÀÎÀº LDLÄÝ·¹½ºÅ×·Ñ Á¶Àý ¸ñǥġÀÇ º¯È¸¦ ¾î´À Á¤...
ÀÌ»óµ· ±âÀÚ
|
2022-11-16 12:10
¶óÀÎ
[Sub Story]
¼±¸´Â ¹» ±Ù°Å·Î 55mg/dL ¹Ì¸¸Á¶Àý ±Ç°íÇß³ª?
LDL-C Á¶Àý ÇÏÇѼ± ÇÏÇâÁ¶Á¤Àü¼¼°èÀûÀ¸·Î ½ÉÀåÇС¤³»ºÐºñÇаèÀÇ ÀÌ»óÁöÁúÇ÷Áõ °¡À̵å¶óÀο¡¼´Â LDLÄÝ·¹½ºÅ×·Ñ Á¶Àý ¸ñǥġ¸¦ Á¡ÁøÀûÀ¸·Î ³»...
ÀÌ»óµ· ±âÀÚ
|
2022-11-16 12:09
¶óÀÎ
[Sub Story]
55mg/dL ¹Ì¸¸ ¸ñǥġ ¾à¹°Ä¡·á¿¡ ¹ÌÄ¡´Â ¿µÇâÀº?
LDL-C 55mg/dLAACE´Â Áö³ 2017³â ÀÌ»óÁöÁúÇ÷Áõ °¡À̵å¶óÀο¡¼ Á׻󵿸ưæȼº ½ÉÇ÷°üÁúȯ(ASCVD) ÃÊ°íÀ§Ç豺(very ...
ÀÌ»óµ· ±âÀÚ
|
2022-11-16 12:03
¶óÀÎ
[Sub Story]
½ÉÇ÷°üÁúȯ 1Â÷¿¹¹æ¿¡ ½ºÅ¸Æ¾ ±Ç°í
40~75¼¼ À§Çèµµ µû¶ó ±Ç°í6³â¿© ¸¸¿¡ °³Á¤µÈ À̹ø ¼º¸íÀº ¾Õ¼± ±Ç°í¾È°ú ºñ±³ÇØ Å« º¯È´Â ¾ø´Ù. ÁÖ¿ä ³»¿ëÀ» º¸¸é, Çϳª ÀÌ»óÀÇ ½É...
ÀÌ»óµ· ±âÀÚ
|
2022-11-16 11:56
¶óÀÎ
[Sub Story]
¿¡Á¦Æ¼¹Ìºê¡¤PCSK9¾ïÁ¦Á¦ ±Ç°íµî±Þ »óÇâ
±Ù°Åµî±Þ »óÇâÁ¶Á¤ÀÌ»óÀÇ ºñ½ºÅ¸Æ¾°è ÁöÁúÄ¡·áÁ¦ ±Ç°í´Â ÀÌÀü°ú ´Ù¸¦ ¹Ù°¡ ¾øÀ¸³ª, ±Ç°íµî±ÞÀÌ »óÇâÁ¶Á¤µÆ´Ù´Â °ÍÀÌ À̹ø ÁöħÀÇ Â÷ÀÌÁ¡ÀÌ´Ù. Áï ¿¡Á¦Æ¼¹Ìºê³ª PCSK9¾ïÁ¦Á¦¸¦ ±Ç°íÇÒ ¼ö ÀÖ´Â ±Ù°ÅµéÀÌ ´õ dzÁ·ÇØÁ³´Ù´Â °ÍÀÌ´Ù...
ÀÌ»óµ· ±âÀÚ
|
2022-11-16 11:52
¶óÀÎ
[Sub Story]
°íÁß¼ºÁö¹æÇ÷Áõ µ¿¹Ý½Ã ½ºÅ¸Æ¾¸¸À¸·Î ½ÉÇ÷°üÁúȯ ¸ø¸·¾Æ
Áß¼ºÁö¹æ Á¶Àý±âÀü°íÁß¼ºÁö¹æÇ÷ÁõÀÇ 1Â÷Ä¡·á¿¡µµ ¿ª½Ã ½ºÅ¸Æ¾ÀÌ ¸ÕÀú »ç¿ëµÈ´Ù. ÇÏÁö¸¸ LDLÄÝ·¹½ºÅ×·Ñ °ÇϱâÀüÀÇ ½ºÅ¸Æ¾ ¸¸À¸·Î´Â Áß¼ºÁö¹æ°ú...
ÀÌ»óµ· ±âÀÚ
|
2022-11-16 11:50
¶óÀÎ
[Interview]
¡°Æä³ëÇǺ극ÀÌÆ® Àå±âÅõ¿© ±Ù°Å ¸¶·ÃÇß´Ù¡±
Q. ±¹³» °íÁß¼ºÁö¹æÇ÷ÁõÀÇ Æ¯Â¡À» Á¤¸®ÇÑ´Ù¸é?Çѱ¹ÁöÁú¡¤µ¿¸Æ°æÈÇÐȸ°¡ ¹ßÇ¥ÇÑ ¡®ÀÌ»óÁöÁúÇ÷Áõ ÆÑÆ®½ÃÆ® 2022¡¯¿¡ ÀÇÇÏ¸é ±¹³» °íÁß¼ºÁö¹æÇ÷...
ÀÓ¼¼Çü ±âÀÚ
|
2022-11-16 11:47
¶óÀÎ
[Drug Review]
·Î¼ö¹Ù½ºÅ¸Æ¾/¿¡Á¦Æ¼¹Ìºê/Åڹ̻縣ź¿¡ ¾Ï·ÎµðÇɱîÁö ´õÇß´Ù
4Á¦ º¹ÇÕÁ¦GC³ì½ÊÀÚ ÃøÀº Áö³´Þ 21ÀÏ °íÇ÷¾Ð°ú ÀÌ»óÁöÁúÇ÷ÁõÀ» µ¿½Ã¿¡ °ø·«ÇÏ´Â 4Á¦ º¹ÇÕÁ¦ ¡®·ÎÁ¦ÅÚÇÉ(Åڹ̻縣ź/¾Ï·ÎµðÇÉ/·Î¼ö¹Ù½ºÅ¸Æ¾...
ÀÌ»óµ· ±âÀÚ
|
2022-11-16 11:38
¶óÀÎ
[Primary Expert Opinion]
[1Â÷ ÀÇ·á±â°ü ½ÃÁ¡ÀÇ ½ÇÁúÀûÀÎ ÀÌ»óÁöÁúÇ÷Áõ °ü¸®Àü·«]
ȯÀÚº° LDL-C ¸ñÇ¥¼³Á¤ Çʿ䡦º¹¿ë¼øÀÀµµ °³¼±¿¡µµ ½Å°æ½á¾ß
ÃÖ±Ù Çѱ¹ÁöÁú¡¤µ¿¸Æ°æÈÇÐȸ¿¡¼´Â ÀÌ»óÁöÁúÇ÷Áõ Áø·áÁöħ 5ÆÇÀ» ¹ßÇ¥ÇÏ¸é¼ º¸´Ù ´õ Àû±ØÀûÀ¸·Î LDL-ÄÝ·¹½ºÅ×·Ñ(LDL-C) ¼öÄ¡¸¦ ³·Ãßµµ...
THE MOST
|
2022-11-16 11:33
-
1
2
3
4
5
6
7
8
9
10
´ÙÀ½
-
¿©¹é
Sub
news
¡°Á¹·¹µå·Î³×ÀÌÆ® °ñÀý¿¹¹æ ÀÓ»ó±Ù°Å¡¤ÀûÀÀÁõ ÃÖ´Ù¡±
Q. °ñÀý¿¹¹æÀ» À§ÇÑ ¾à¹°Ä¡·á´Â ¾î¶»°Ô ±Ç°í...
¡°CGM ¿¬µ¿ Àν¶¸°¿ä¹ý °í³µµ ±â¼úÀû Áö½Ä ¿äÇÏ´Â Ä¡·á°úÁ¤¡±
Q. ´ç´¢º´ Ä¡·á½Ã CGM ÀÓ»óÀû ¿ªÇÒÀº?ÀÓ...
¡°·Î¼ö¹Ù½ºÅ¸Æ¾ 20³â ±Ù°Å·Î ¼öÆÛ½ºÅ¸Æ¾ ¸í¼º À¯ÁöÇÒ °Í¡±
Q. ´ç´¢º´ ȯÀÚ¿¡¼ ÁöÁúÄ¡·á°¡ ÇÊ¿äÇÑ ÀÌÀ¯...
¿©¹é
¿©¹é
Back to Top